Find your next M&A target

Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.

Project details

Israeli biomedical company has a IVF project and seeks investment.

Project region Israel
Industry Healthcare
Total value of the target N/A
Expected target net rate of return after deducting all taxes and fees N/A
Validity period of pending order 365


  • Simon Laube

    Simon Laube

    Assistant Manager, International Business Advisory

Project highlights IVF treatment - proprietary technology - clinical trial phase
Project description

The Israeli biomedicine company’s project improves the success rate of IVF treatment based on its proprietary technology, which determines the patient's uterine preparation through continuous real-time monitoring in vivo. This personalized medical solution provides direct information about the condition of the endometrium. At present, it has raised 1.5 million US dollars, which is mainly used to continue clinical trials and expand its intellectual property rights and complete prototype design. It is planned to submit documents for registration within one and a half years upon which the business will start.

Enquire for more information about our services, and how we can help solve challenges for your organization

Contact Us
The code is case-sensitive